Type 2 diabetes-induced cardiovascular complications: comparative evaluation of spironolactone, atenolol, metoprolol, ramipril and perindopril

Beneficial role of telmisartan on cardiovascular complications associated with STZ-induced type 2 diabetes in rats

(2014) Bhoomika R. Goyal et al.   Pharmacological Reports

Aldosterone and angiotensin: Role in diabetes and cardiovascular diseases

(2012) Bhoomika M. Patel et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Perindopril protects against streptozotocin-induced hyperglycemic myocardial damage/alterations

(2012) BM Patel et al.   HUMAN & EXPERIMENTAL TOXICOLOGY

Diabetic cardiomyopathy

(2012) BR Goyal et al.   HUMAN & EXPERIMENTAL TOXICOLOGY

Azelnidipine protects myocardium in hyperglycemia-induced cardiac damage

(2010) Vasundhara Kain et al.   Cardiovascular Diabetology

Investigation Into the Cardiac Effects of Spironolactone in the Experimental Model of Type 1 Diabetes

(2009) Bhoomika R Goyal et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

Prediabetic and diabetic in vivo modification of circulating low-density lipoprotein attenuates its stimulatory effect on adrenal aldosterone and cortisol secretion

(2008) Steffi Kopprasch et al.   JOURNAL OF ENDOCRINOLOGY

Effect of telmisartan on cardiovascular complications associated with streptozotocin diabetic rats

(2008) Bhoomika R. Goyal et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY